-
Mashup Score: 1Translational Science Training Course - 9 hour(s) ago
The ASTCT Translational Science Training Course is a program for young researchers and scientists involved in bench and translational science in the hematopoietic stem cell transplantation and cell therapy field. The course provides an opportunity for 12 scholars to work 1:1 with the course faculty through formal presentations and extensive follow-up dialogue and small-group discussion.
Source: www.astct.orgCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 4Translational Science Training Course - 2 day(s) ago
The ASTCT Translational Science Training Course is a program for young researchers and scientists involved in bench and translational science in the hematopoietic stem cell transplantation and cell therapy field. The course provides an opportunity for 12 scholars to work 1:1 with the course faculty through formal presentations and extensive follow-up dialogue and small-group discussion.
Source: www.astct.orgCategories: General Medicine News, Oncologists1Tweet-
Applications for the 2025 Translational Science Training Course are now open! This course provides an opportunity for lab-based PhDs/MDs to develop their research project into a "presentation-ready" talk. Learn more: https://t.co/NFfXwRuY4m https://t.co/BcjASIX1HY
-
-
Mashup Score: 4Joint Scientific Meeting - 3 day(s) ago
The American Society for Transplantation and Cellular Therapy is an international professional membership association of more than 3,900 physicians, investigators and other health care professionals from more than 50 countries. Our mission is dedicated to improving the application and success of hematopoietic cell transplantation and related cellular therapies. We strive to be the leading organization promoting research, education and clinical practice in the field.
Source: www.astct.orgCategories: General Medicine News, Oncologists1Tweet-
ASTCT + @TheEBMT are now accepting abstracts to the #SciMeeting25! 💡 Present your findings to global experts in #HCT and #cellulartherapy and submit an abstract by Feb. 21: https://t.co/bQfM900aay https://t.co/m8SvA9JdsA
-
-
Mashup Score: 4Translational Science Training Course - 6 day(s) ago
The ASTCT Translational Science Training Course is a program for young researchers and scientists involved in bench and translational science in the hematopoietic stem cell transplantation and cell therapy field. The course provides an opportunity for 12 scholars to work 1:1 with the course faculty through formal presentations and extensive follow-up dialogue and small-group discussion.
Source: www.astct.orgCategories: General Medicine News, Oncologists1Tweet-
Applications for the 2025 Translational Science Training Course are now open! This course provides an opportunity for lab-based PhDs/MDs to develop their research project into a "presentation-ready" talk. Learn more: https://t.co/NFfXwRuY4m https://t.co/BcjASIX1HY
-
-
Mashup Score: 4Regulation of CAR T cell exhaustion and effects of IL-4 - 6 day(s) ago
Stewart CM, Siegler EL, Sakemura RL, et al. IL-4 Drives Exhaustion of CD8-Positive CART Cells. Nature Communications. 2024; (doi: 10.1038/s41467-024-51978-3). Researchers say interleukin 4…
Source: www.astct.orgCategories: General Medicine News, Oncologists1Tweet-
Researchers say interleukin 4 (IL-4) is implicated in chimeric antigen receptor (CAR) T-cell exhaustion — a primary factor blocking durable response to CAR immunotherapy — and thus may represent a pathway to improved efficacy. Read more on Nucleus: https://t.co/lsHDnvtavK https://t.co/eZXhnNhzKd
-
-
Mashup Score: 0A Phase 1 Clinical Trial of NKTR-255 With CD19-22 CAR T-Cell Therapy for Refractory B-Cell Acute Lymphoblastic Leukemia - 7 day(s) ago
Researchers at Stanford University have conducted a phase 1 clinical trial (#NCT03233854) evaluating the combination of a bispecific chimeric antigen receptor (CAR) T-cell therapy targeting CD19…
Source: www.astct.orgCategories: General Medicine News, Oncologists1Tweet-
Researchers @StanfordMed have conducted a phase 1 clinical trial (#NCT03233854) evaluating the combination of a bispecific CAR T-cell therapy targeting CD19 and CD22 (CAR19-22) with NKTR-255, a novel recombinant polymer-conjugated IL15 receptor agonist. https://t.co/UWyDWLfzTb https://t.co/tZepUcNSZv
-
-
Mashup Score: 4Translational Science Training Course - 7 day(s) ago
The ASTCT Translational Science Training Course is a program for young researchers and scientists involved in bench and translational science in the hematopoietic stem cell transplantation and cell therapy field. The course provides an opportunity for 12 scholars to work 1:1 with the course faculty through formal presentations and extensive follow-up dialogue and small-group discussion.
Source: www.astct.orgCategories: General Medicine News, Oncologists1Tweet-
Applications for the 2025 Translational Science Training Course are now open! This course provides an opportunity for lab-based PhDs/MDs to develop their research project into a "presentation-ready" talk. Learn more: https://t.co/NFfXwRuY4m https://t.co/BcjASIX1HY
-
-
Mashup Score: 4Translational Science Training Course - 14 day(s) ago
The ASTCT Translational Science Training Course is a program for young researchers and scientists involved in bench and translational science in the hematopoietic stem cell transplantation and cell therapy field. The course provides an opportunity for 12 scholars to work 1:1 with the course faculty through formal presentations and extensive follow-up dialogue and small-group discussion.
Source: www.astct.orgCategories: General Medicine News, Oncologists1Tweet-
Applications for the 2025 Translational Science Training Course are now open! This course provides an opportunity for lab-based PhDs/MDs to develop their research project into a "presentation-ready" talk. Learn more: https://t.co/NFfXwRuY4m https://t.co/BcjASIX1HY
-
-
Mashup Score: 1Radiomic cytoreduction and bridging therapy to predict outcomes after CAR T-cell therapy in LBCL - 14 day(s) ago
Hubbeling H, Leithner D, Silverman EA, et al. Metabolic Tumor Volume Response After Bridging Therapy Determines Chimeric Antigen Receptor T-Cell Outcomes in Large B-Cell Lymphoma. Clinical Cancer…
Source: www.astct.orgCategories: General Medicine News, Oncologists1Tweet-
Patients with high tumor burden are predisposed to less favorable outcomes after chimeric antigen receptor T-cell (CAR T) therapy, but researchers say radiomic cytoreduction achieved during bridging therapy (BT) can improve their prognosis. Read more: https://t.co/MHXCnNtaiS https://t.co/ZDDcVhj7AJ
-
-
Mashup Score: 2Fundamentals of HCT Training Course - 16 day(s) ago
The American Society for Transplantation and Cellular Therapy is an international professional membership association of more than 3,900 physicians, investigators and other health care professionals from more than 50 countries. Our mission is dedicated to improving the application and success of hematopoietic cell transplantation and related cellular therapies. We strive to be the leading organization promoting research, education and clinical practice in the field.
Source: www.astct.orgCategories: General Medicine News, Oncologists1Tweet-
The 2025 Fundamentals of HCT Training Course is a 2-day virtual course that will provide a broad intro & overview of #HCT & cellular immunotherapy, with a strong focus on pharmacotherapeutic management. Registration is now open: https://t.co/rAisZ3RcHP https://t.co/XejlTCz3VC
-
Applications for the 2025 Translational Science Training Course are now open! This course provides an opportunity for lab-based PhDs/MDs to develop their research project into a "presentation-ready" talk. Learn more: https://t.co/NFfXwRuY4m https://t.co/BcjASIX1HY